Which has the lower trailing P/E, HUM or RHHBY?

RHHBY has the lower trailing P/E: HUM trades at 37.03 and RHHBY at 16.15. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, HUM or RHHBY?

Over the past five years, HUM grew revenue faster — HUM at a 12.61% CAGR versus RHHBY at 3.94%.

Does HUM or RHHBY pay a bigger dividend?

HUM yields 0.91% and RHHBY yields 2.75% based on trailing dividends and the latest price.

Is HUM or RHHBY more profitable?

RHHBY runs the higher net margin — HUM at 0.88% versus RHHBY at 20.33%.

How have HUM and RHHBY total returns compared?

Over the past 10 years, HUM delivered 9.15% and RHHBY delivered 9.59% annualized total return. Past performance doesn't predict future results.

Humana Inc. (HUM) vs Roche Holding AG (RHHBY)

A side-by-side comparison of Humana Inc. and Roche Holding AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 27, 2026. Differences are shown without an overall score or investment verdict.

HUM

Humana Inc.

$47.15B

$392.63HealthcareDelayed quote: Aug 27, 2026, 4:02 PM EDT

RHHBY

Roche Holding AG

$359.46B

$56.39HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

Total return — HUM vs RHHBY

growth of $100 · dividends reinvested · last 10y

HUM +138.1% (+9.1%/yr)RHHBY +146.1% (+9.4%/yr)RHHBY compounded faster over this window

HUM RHHBY

HUM vs RHHBY: by the numbers

•RHHBY is the larger company ($359.46B vs $47.15B market cap).
•RHHBY trades at the lower trailing earnings multiple (16.15 vs 37.03 P/E), one valuation lens rather than an overall verdict.
•RHHBY converts more revenue to profit (20.33% vs 0.88% net margin).
•HUM grew revenue faster over the past five years (12.61% vs 3.94% CAGR).
•RHHBY pays the higher dividend yield (2.75% vs 0.91%).

Metrics side by side

Valuation

Metric	HUM	RHHBY
P/E ratio	37.03	16.15
Forward P/E	42.72	22.83
P/S ratio	0.32	4.53
P/B ratio	2.46	9.06
EV / EBITDA	19.70	14.21
FCF yield	2.71%	4.69%

Profitability

Metric	HUM	RHHBY
Gross margin	13.65%	73.73%
Operating margin	1.39%	29.16%
Net margin	0.88%	20.33%
ROE	6.65%	38.06%
ROIC	4.52%	19.71%

Dividends

Metric	HUM	RHHBY
Dividend yield	0.91%	2.75%
Payout ratio	35.87%	60.81%

Growth (annualized)

Metric	HUM	RHHBY
Revenue CAGR (5Y)	12.61%	3.94%
EPS CAGR (5Y)	-17.27%	1.54%
FCF CAGR (5Y)	-17.19%	5.54%
Total return CAGR (5Y)	0.41%	5.84%

Frequently asked

Which has the lower trailing P/E, HUM or RHHBY?: RHHBY has the lower trailing P/E: HUM trades at 37.03 and RHHBY at 16.15. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, HUM or RHHBY?: Over the past five years, HUM grew revenue faster — HUM at a 12.61% CAGR versus RHHBY at 3.94%.
Does HUM or RHHBY pay a bigger dividend?: HUM yields 0.91% and RHHBY yields 2.75% based on trailing dividends and the latest price.
Is HUM or RHHBY more profitable?: RHHBY runs the higher net margin — HUM at 0.88% versus RHHBY at 20.33%.
How have HUM and RHHBY total returns compared?: Over the past 10 years, HUM delivered 9.15% and RHHBY delivered 9.59% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HUM analysis Full RHHBY analysis Interactive comparison tool

Dig into the metrics

Humana P/E ratio Roche Holding AG P/E ratio Humana dividend yield Roche Holding AG dividend yield Humana ROE Roche Holding AG ROE Humana operating margin Roche Holding AG operating margin Humana revenue growth Roche Holding AG revenue growth Humana free cash flow Roche Holding AG free cash flow

Humana & Roche Holding AG appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 27, 2026.